Sexually Transmitted Infections

2 months ago | sti.bmj.com | Hoai Nguyen |Hoài Nguyễn |Minh Pham |Cao Nguyên |cao nguyen |Paul Adamson

AbstractBackground Mycoplasma genitalium (MG) is a critical pathogen of sexually transmitted infections (STIs) in men, associated with high antibiotic resistance. Understanding the clinical characteristics of MG infections can improve testing and treatment guidelines. Aims To investigate the clinical features and characteristics of asymptomatic, acute and chronic MG infections in heterosexual males.

Jan 13, 2025 | sti.bmj.com | Jennifer C Ratner |Janet Wilson |Kevin Roberts |catherine armitage

AbstractObjectives Azoles have been the mainstay of recurrent vulvovaginal candidiasis (RVVC) for many years. Because of a recent anecdotal increase in non-Candida albicans yeasts (NCAY) and azole-resistant C. albicans cases, their prevalence was calculated from cultures for yeasts in women with complicated/RVVC over 3 years. Methods Retrospective data search of vaginal cultures from adult women in Leeds, UK between April 2018 and March 2021 was conducted.

Jan 11, 2025 | sti.bmj.com | Drieda Zace |Marina Daskalopoulou |Rachel Herbert |Giovanni Villa

Viral suppression (VS) following initiation of long-acting cabotegravir/rilpivirine (LA-CAB/RPV) among people with HIV, adherence challenges and baseline viraemiaThe Ward 86 publicly funded San Francisco HIV clinic serves people experiencing socioeconomic, psychological and adherence challenges. This study examined the persistence of LA-CAB/RPV and durability of VS (HIV RNA <50 c/mL) at 48 weeks among 59 participants (53% unstable housing, 63% substance use and 49% CD4 <200 cells/mm3).

Nov 18, 2024 | sti.bmj.com | Nadja A. Vielot |Weiming Tang |Giovanni Villa

Published in STI: men who have sex with men frequently receive antibiotics despite negative STI testsThe Sydney Sexual Health Centre guidelines indicate immediate presumptive antibiotic treatment for men who have sex with men (MSM) with anogenital symptoms, in addition to laboratory-based three-site molecular testing for Chlamydia trachomatis (CT) and Neisseria gonorrhoea (GC).

Oct 17, 2024 | sti.bmj.com | Rachel Herbert |Marina Daskalopoulou

Gender and ethnicity disparity in HIV pre-exposure prophylaxis use following routine commissioning in EnglandIn England, HIV pre-exposure prophylaxis (PrEP) was initially available through the Impact trial (2017–2020), which primarily comprised of men who have sex with men (MSM)1. This study compared changes in PrEP access following the roll-out of commissioned, routine HIV PrEP in 2021. Overall PrEP use increased threefold, with use in heterosexual men increasing from 1% to 13%.